MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0148985
Galaxystar Pharma Distributors Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹357.78 Cr
▲ 25% YoY
Net profit · FY 2025
₹2.65 Cr
Net margin 0.7%
EBITDA · FY 2025
₹9.42 Cr
EBITDA margin 2.6%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹21 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
63
Provident fund records
About Galaxystar Pharma Distributors Private Limited
Data last updated:
Galaxystar Pharma Distributors Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Entero Healthcare Solutions Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2018PTC314815. Its GSTIN is 27AAHCG4762H1ZE (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Vikramaditya Harishchandra Ambre (Whole-Time Director) and Amit Mangilal Bishnoi.
Its last annual general meeting (AGM) was held on 16 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot 81 – A Tahira Compound Caves Road Jogeshwari East, Mumbai, Maharashtra, India – 400060.
As per the financials filed for FY 2025, the company reported a revenue of ₹357.78 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹2.65 Cr (net margin 0.7%) and EBITDA of ₹9.42 Cr (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 31% over five years.
The company has about 63 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹21 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company; 1 case is pending. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in June 2022. Its 10 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Purani Hospital Supplies Private Limited with revenue of ₹379 Cr.
Galaxystar Pharma Distributors Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0148985). For more details, the company can be reached via its website enterohealthcare.com.
Company Details of Galaxystar Pharma Distributors Private Limited
CIN U51909MH2018PTC314815
Registration Number 314815
Incorporation Date 26 September 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 16 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Entero Healthcare Solutions Limited
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0148985
Key People
Vikramaditya Harishchandra Ambre Whole-Time Director Sumitra Sachin Jadhav Additional Director Amit Mangilal Bishnoi Director Recognitions & Rankings of Galaxystar Pharma Distributors
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot 81 – A Tahira Compound Caves Road Jogeshwari East, Mumbai, Maharashtra, India – 400060
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Galaxystar Pharma Distributors Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Galaxystar Pharma Distributors Private Limited
The main business activity of Galaxystar Pharma Distributors is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Galaxystar Pharma Distributors Private Limited FY 2025 filings available
Galaxystar Pharma Distributors Private Limited reported revenue of ₹357.78 Cr (up 25% YoY) for FY 2025.
Revenue · FY 2025
₹357.78 Cr ▲ 25%
Net profit · FY 2025
₹2.65 Cr margin 0.7%
EBITDA · FY 2025
₹9.42 Cr margin 2.6%
Compounded Annual Growth Rate (CAGR) of Galaxystar Pharma Distributors Private Limited
Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 26%
5 years · compounded
▲ 31%
EBITDA CAGR growth
1 year
▲ 53%
3 years · compounded
▲ 18%
5 years · compounded
▲ 32%
Revenue has grown at a compounded annual rate (CAGR) of 31% over five years, including 25% growth in the latest year. EBITDA rose 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Galaxystar Pharma Distributors Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹9.42 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.65 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Galaxystar Pharma Distributors Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Galaxystar Pharma Distributors are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Galaxystar Pharma Distributors Private Limited
Galaxystar Pharma Distributors has 5 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumitra Sachin Jadhav | Additional Director | 12 Jan 2026 | 0 Years 9 Months | Current |
| Amit Mangilal Bishnoi Also directs: Sundarlal Pharma Distributors Private Limited | Director | 22 Mar 2024 | 2 Years 7 Months | Current |
| Vikramaditya Harishchandra Ambre Also directs: Sundarlal Pharma Distributors Private Limited | Whole-Time Director | 26 Sep 2018 | 8 Years 0 Months | Current |
| Gaurav Kumar | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
| Manish Kumar | Director | 26 May 2025 | 1 Years 4 Months | Current |
Peer Comparison of Galaxystar Pharma Distributors Private Limited
Galaxystar Pharma Distributors Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Purani Hospital Supplies Private Limited | ₹379 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Coimbatore, Tamil Nadu, India |
| Martin and Harris Enterprises Private Limited | ₹373.99 Cr (FY 2025) | •••• | •••• | 675.0% | •••• | Mumbai, Maharashtra, India |
| R S M Pharma Private Limited | ₹363.29 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Bangalore, Karnataka, India |
| A M Pharmaceuticals (India) Private Limited | ₹359.11 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Thrissur, Kerala, India |
| Gsa Surgical & Medicines Private Limited | ₹358.65 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Kolkata, West Bengal, India |
| Galaxystar Pharma Distributors Private Limited this company | ₹357.78 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Mumbai, Maharashtra, India |
| Pangea Enterprises Private Limited | ₹353.08 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | New Delhi, Delhi, India |
| Sai Sridhar Pharma Private Limited | ₹349.28 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Hyderabad, Telangana, India |
| VPD Medi India Private Limited | ₹349.1 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Ahmedabad, Gujarat, India |
| Medihauxe International India Private Limited | ₹347.83 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Chennai, Tamil Nadu, India |
| Thea Technologies Private Limited | ₹343.52 Cr (FY 2019) | •••• | •••• | 218.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Galaxystar Pharma Distributors by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Galaxystar Pharma Distributors Private Limited
Galaxystar Pharma Distributors Private Limited is audited by M S K A & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M S K A & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Galaxystar Pharma Distributors Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Galaxystar Pharma Distributors Private Limited
Open charges
₹21 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2020 | Others | ₹21 Cr | Open |
Total charge records: 1 View all charges
Deals & Funding of Galaxystar Pharma Distributors Private Limited
Galaxystar Pharma Distributors Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in June 2022.
Total deals
2
Rights issue
1
Secondary share transfer
1
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2022 | Rights issue | ₹99 Lakh | Investors: Entero Healthcare Solutions Limited |
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: Entero Healthcare Solutions Limited , Entero Healthcare Solutions Limited & Prabhat Agrawal Seller: 2 individuals |
Premium access
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Galaxystar Pharma Distributors Private Limited
Galaxystar Pharma Distributors Private Limited has 3 court cases on record: 3 filed by Galaxystar Pharma Distributors. 1 case is pending and 2 are disposed. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Total cases
3
Filed by the company
3
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Disposed |
Premium access
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Galaxystar Pharma Distributors Private Limited
Galaxystar Pharma Distributors Private Limited has a workforce of 63 employees as of Mar 30, 2024.
Employee count
63
Active EPFO establishments
1
Employee growth
34.04%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Galaxystar Pharma Distributors Private Limited
Galaxystar Pharma Distributors Private Limited has 16 board changes on record since 2018: 5 appointments and 11 cessations. The latest: Sumitra Sachin Jadhav was appointed as Additional Director on 12 Jan 2026.
Appointed
Sumitra Sachin Jadhav was appointed as Additional Director.
AGM
Galaxystar Pharma Distributors Private Limited last Annual general meeting of members was held on 16 Sep 2025 as per latest MCA records.
Ceased
Manish Kumar ceased to be Additional Director.
Ceased
Sanu Vishal Kapoor ceased to be Additional Director.
Appointed
Manish Kumar was appointed as Director.
Filing
Galaxystar Pharma Distributors Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Amit Mangilal Bishnoi ceased to be Additional Director.
Ceased
Vikramaditya Harishchandra Ambre ceased to be Director.
Appointed
Amit Mangilal Bishnoi was appointed as Director.
Ceased
Akshay Jain ceased to be Additional Director.
Charges
A charge with Others of Rs. 21.00 Cr registered on 18 Sep 2020 with Charge ID 100377104 was modified on 28 Dec 2023.
Ceased
Abhitesh Kumar ceased to be Director.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Galaxystar Pharma Distributors Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Galaxystar Pharma Distributors Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Galaxystar Pharma Distributors Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Galaxystar Pharma Distributors Private Limited
Galaxystar Pharma Distributors has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCG4762H1ZE | Maharashtra | Active | 21 Dec 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Galaxystar Pharma Distributors Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Galaxystar Pharma Distributors Private Limited
Galaxystar Pharma Distributors is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 September 2018 (8+ years old) and is registered under CIN U51909MH2018PTC314815.
Galaxystar Pharma Distributors reported revenue of ₹357.78 Cr for FY 2025 (up 25% YoY).
Galaxystar Pharma Distributors has 5 current directors:
- Vikramaditya Harishchandra Ambre - Whole-Time Director
- Sumitra Sachin Jadhav - Additional Director
- Amit Mangilal Bishnoi - Director
- Gaurav Kumar - Director
- Manish Kumar - Director
Galaxystar Pharma Distributors reported a net profit of ₹2.65 Cr (net margin 0.7%) and EBITDA of ₹9.42 Cr (EBITDA margin 2.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Galaxystar Pharma Distributors is 26% over three years and 31% over five years. In the latest year (FY 2025) revenue rose 25%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Galaxystar Pharma Distributors is 27AAHCG4762H1ZE, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Galaxystar Pharma Distributors is U51909MH2018PTC314815. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Galaxystar Pharma Distributors has 3 court cases on record: 3 filed by the company. 1 is pending.
Galaxystar Pharma Distributors was incorporated on 26 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Galaxystar Pharma Distributors has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in June 2022.
The peers of Galaxystar Pharma Distributors by revenue are Purani Hospital Supplies Private Limited, Martin and Harris Enterprises Private Limited, R S M Pharma Private Limited, A M Pharmaceuticals (India) Private Limited, Gsa Surgical & Medicines Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution).